# OnCo record pyxis-oncology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/pyxis-oncology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "pyxis-oncology" ;
  schema:name "Pyxis Oncology"@en ;
  schema:alternateName "Pyxis Oncology, Inc."@en, "Pyxis Oncology, Inc"@en ;
  schema:description "A listed Boston company developing an antibody-drug conjugate, a drug that carries a toxin into the tumour, aimed at a protein found in the tissue around cancers. It is in early trials, mainly for head and neck cancer that has come back or spread."@en ;
  schema:url <https://onco.cc/companies/pyxis-oncology/>, <https://pyxisoncology.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://pyxisoncology.com/>, <https://pyxisoncology.com/clinical-programs/>, <https://clinicaltrials.gov/study/NCT05720117>, <https://clinicaltrials.gov/study/NCT06795412>, <https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001782223>, <https://www.racap.com/portfolio/pyxis-oncology> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/recurrent-metastatic-hnscc/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/fn1/> ;
  onco:drugs <https://onco.cc/drugs/micvotabart-pelidotin/> ;
  onco:trials <https://onco.cc/trials/nct06795412/> .